|
VRK2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.319800E-03 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.135800E-02 |
| Normal-vs-Stage2 |
3.406300E-02 |
| Normal-vs-Stage3 |
4.663600E-02 |
| Normal-vs-Stage4 |
4.471700E-02 |
| Stage1-vs-Stage2 |
4.022200E-01 |
| Stage1-vs-Stage3 |
9.465600E-01 |
| Stage1-vs-Stage4 |
7.901200E-01 |
| Stage2-vs-Stage3 |
4.092800E-01 |
| Stage2-vs-Stage4 |
5.620400E-01 |
| Stage3-vs-Stage4 |
7.693800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.402880E-03 |
| Normal-vs-AfricanAmerican |
2.820000E-01 |
| Normal-vs-Asian |
3.946400E-02 |
| Caucasian-vs-AfricanAmerican |
2.00339999999466E-05 |
| Caucasian-vs-Asian |
4.910600E-01 |
| AfricanAmerican-vs-Asian |
7.336000E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.843000E-03 |
| Normal-vs-Female |
1.153600E-02 |
| Male-vs-Female |
7.600200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.705400E-01 |
| Normal-vs-Age(41-60Yrs) |
1.287830E-02 |
| Normal-vs-Age(61-80Yrs) |
3.599700E-03 |
| Normal-vs-Age(81-100Yrs) |
2.615400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.843400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.455400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.610200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.408200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.636800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.062000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.835380E-01 |
| Normal-vs-Grade 2 |
2.184500E-03 |
| Normal-vs-Grade 3 |
4.134500E-02 |
| Normal-vs-Grade 4 |
5.289900E-02 |
| Grade 1-vs-Grade 2 |
7.115000E-01 |
| Grade 1-vs-Grade 3 |
8.046800E-01 |
| Grade 1-vs-Grade 4 |
8.925400E-01 |
| Grade 2-vs-Grade 3 |
1.789840E-01 |
| Grade 2-vs-Grade 4 |
7.950000E-01 |
| Grade 3-vs-Grade 4 |
5.632600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.003910E-04 |
| Normal-vs-ccB subtype |
1.633530E-02 |
| ccA subtype-vs-ccB subtype |
9.830000E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.078900E-03 |
| Normal-vs-N1 |
3.069600E-02 |
| N0-vs-N1 |
5.465200E-01 |
|
|
